NEW YORK, July 27 – Aclara Biosciences said Friday that its revenues dropped slightly during the second quarter of 2001, to $849,000 from $950,000 during the same period a year ago.

The decrease is a result of lower revenue from the company’s collaborations, the manufacturer of lab-on-a-chip microfluidic assay devices said. The revenue decrease was partially offset by higher revenue from product sales and research grants.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.